|
|
 |
 |
|
Home > About Asthma Action America®
About Asthma Action America®
Asthma Action America® is a national asthma education campaign supported by leading organizations committed to improving healthcare. More than 30 million Americans have been diagnosed with asthma in their lifetime,
including an estimated 9 million children under the age of 18. Asthma is a leading cause of activity limitation in the United States, and it places a significant burden not only on patients, but also on families, workplaces, schools, communities, and
quality of life. In fact:
|
|
 |
|
- The prevalence of asthma is rising at a faster rate than any other chronic disease in
America today
- The estimated annual cost for treating asthma in those under 18 years of age is
$3.2 billion.
- Asthma is the third-leading cause of preventable hospitalizations in the United States.
- The number of asthma deaths is significantly higher today than two decades ago. In 2001, there were approximately 4,000 asthma-related deaths in
the United States.
- In 2002, the total cost of asthma was estimated to be $14 billion, including $4.6 billion in indirect costs
(e.g., lost productivity).
The statistics above are an indicator that asthma has significant impact on the public health. They also outline a need to inform and educate asthma patients on how they can more effectively manage their condition.
Asthma Action America® Background
Asthma Action America® is a national asthma education program supported by 21 leading organizations, including the Respiratory Institute established by GlaxoSmithKline, working together to improve the understanding and management of asthma in the United States. GlaxoSmithKline is a research-based pharmaceutical company and a world leader in respiratory care.
|
|
|
|
Is It Asthma?
Informacion en Español